Stable protein formulations

The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tole...

Full description

Saved in:
Bibliographic Details
Main Authors MANISHA M. DALI, RAJESH B. GANDHI, SUNITA BORSADIA, CHARLES E. DAHLHEIM, MANOJ NERURKAR, VIJAY H. NARINGREKAR
Format Patent
LanguageEnglish
Published 05.07.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
AbstractList The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
Author VIJAY H. NARINGREKAR
RAJESH B. GANDHI
CHARLES E. DAHLHEIM
MANISHA M. DALI
MANOJ NERURKAR
SUNITA BORSADIA
Author_xml – fullname: MANISHA M. DALI
– fullname: RAJESH B. GANDHI
– fullname: SUNITA BORSADIA
– fullname: CHARLES E. DAHLHEIM
– fullname: MANOJ NERURKAR
– fullname: VIJAY H. NARINGREKAR
BookMark eNrjYmDJy89L5WSQDi5JTMpJVSgoyi9JzcxTSMsvyi3NSSzJzM8r5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgYGZsbGBqaWxo6GxsSpAgD8qyZN
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2006330593A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2006330593A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:20:54 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2006330593A13
Notes Application Number: AU20060330593
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070705&DB=EPODOC&CC=AU&NR=2006330593A1
ParticipantIDs epo_espacenet_AU2006330593A1
PublicationCentury 2000
PublicationDate 20070705
PublicationDateYYYYMMDD 2007-07-05
PublicationDate_xml – month: 07
  year: 2007
  text: 20070705
  day: 05
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 2.6767044
Snippet The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Stable protein formulations
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070705&DB=EPODOC&locale=&CC=AU&NR=2006330593A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMbM0Tk00NEvVNUu2SAJ2UAwtdBNN01J0TROBFWxyiqVRSgpoc7Kvn5lHqIlXhGkEE0MObC8M-JzQcvDhiMAclQzM7yXg8roAMYjlAl5bWayflAkUyrd3C7F1UYP1js2B0FTNxcnWNcDfxd9ZzdkZ2JNU8wsC95yBXXdTS2NHYF-JFdiQNgflB9cwJ9C-lALkSsVNkIEtAGheXokQA1NqnjADpzPs7jVhBg5f6JQ3kAnNfcUiDNLAlmFSTqoC-GyFzDwFUHsTevtWsSiDsptriLOHLtCWeLin4h1DkZ1kLMbAAuzup0owKKQZplmaJJmlWSSampskplpYWKakJScCW_aGacnGiamGkgwy-EySwi8tzcAFG500MJVhYCkpKk2VBVarJUly4NAAAGY6exY
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsW5qQWlb0Vrm348DNn6QdW1G9LJ3kraJjAYddiK_77X0OqeRl5CApcP-OXul-TuAO4NW2NUNZhiZFaKBEW1FEp4rhCKCjbL7ac8r52Tw8gIlvrriqw6sGl9YUSc0B8RHBERlSHeK3Feb_8vsVzxt7J8SNfY9Pnsx2NXbtmxiYXI7nTsLebu3JEdB5mkHL0L5ozUndjaBLnSARrZZo0H72Na-6Vsd5WKfwKHC5RXVKfQYUUfek6be60PR2Hz5I3VBn3lGQzRMkw3TBKxFdaFVNubTfat8hzufC92AgVHSf4WlUyWu1PSLqCLdJ9dgsRVbuupwS1KTJ0yy7JznlG07FWeaZSpAxjtk3S1v_sWekEczpLZS_Q2hOP2pvKRjKBbfX2za1SxVXojduYXVmx-CQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Stable+protein+formulations&rft.inventor=MANISHA+M.+DALI&rft.inventor=RAJESH+B.+GANDHI&rft.inventor=SUNITA+BORSADIA&rft.inventor=CHARLES+E.+DAHLHEIM&rft.inventor=MANOJ+NERURKAR&rft.inventor=VIJAY+H.+NARINGREKAR&rft.date=2007-07-05&rft.externalDBID=A1&rft.externalDocID=AU2006330593A1